Fosun Pharmaceutical Shanghai Sells 1,300 Shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) major shareholder Fosun Pharmaceutical Shanghai sold 1,300 shares of the firm’s stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $13.12, for a total value of $17,056.00. Following the sale, the insider now owns 66,467 shares in the company, valued at $872,047.04. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Fosun Pharmaceutical Shanghai also recently made the following trade(s):

• On Thursday, October 10th, Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature’s Sunshine Products stock. The shares were sold at an average price of $13.39, for a total value of $40,170.00.
• On Tuesday, October 8th, Fosun Pharmaceutical Shanghai sold 1,800 shares of Nature’s Sunshine Products stock. The shares were sold at an average price of $13.13, for a total value of $23,634.00.
• On Tuesday, October 1st, Fosun Pharmaceutical Shanghai sold 1,399 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.54, for a total value of $18,942.46.

Nature’s Sunshine Products Price Performance

Shares of NASDAQ:NATR opened at $13.32 on Thursday. Nature’s Sunshine Products, Inc. has a 1 year low of $10.81 and a 1 year high of $21.72. The company has a market cap of $249.48 million, a PE ratio of 15.67 and a beta of 0.87. The stock’s 50-day moving average is $13.39 and its 200 day moving average is $15.48.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). Nature’s Sunshine Products had a net margin of 3.50% and a return on equity of 9.79%. The business had revenue of $110.55 million for the quarter.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Canaccord Genuity Group assumed coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 price objective on the stock. Canaccord Genuity Group assumed coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 price objective on the stock. StockNews.com upgraded Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 10th. Finally, DA Davidson decreased their price objective on Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, August 12th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of NATR. Wasatch Advisors LP increased its holdings in Nature’s Sunshine Products by 20.6% during the 1st quarter. Wasatch Advisors LP now owns 518,161 shares of the company’s stock valued at $10,762,000 after purchasing an additional 88,433 shares during the period. BNP Paribas Financial Markets boosted its position in Nature’s Sunshine Products by 12.7% during the 1st quarter. BNP Paribas Financial Markets now owns 15,207 shares of the company’s stock valued at $316,000 after acquiring an additional 1,715 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in Nature’s Sunshine Products by 8.9% during the 1st quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company’s stock valued at $523,000 after acquiring an additional 2,054 shares in the last quarter. SG Americas Securities LLC boosted its position in Nature’s Sunshine Products by 48.7% during the 1st quarter. SG Americas Securities LLC now owns 10,716 shares of the company’s stock valued at $223,000 after acquiring an additional 3,510 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System boosted its position in Nature’s Sunshine Products by 17.0% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 71,196 shares of the company’s stock valued at $1,479,000 after acquiring an additional 10,354 shares in the last quarter. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.